讨论
hero1802-21 22:50
$Vincerx Pharma(VINC)$ 不畏高，追涨。
简介：Vincerx Pharma, Inc.于2018年12月19日在特拉华州成立。他们是一家临床阶段的生物制药公司，专注于利用其广泛的开发和肿瘤学专业知识来推进解决未满足的癌症治疗与医疗需求的新疗法。他们认为，这些候选产品不同于当前针对类似癌症生物学的项目，如果获得批准，可能会改善癌症患者的临床结果。
| 今开：0.835 | 昨收：0.8172 |
| 最高：0.8407 | 最低：0.787 |
| 涨停价： | 跌停价： |
| 总市值：22753113 |
hero1802-21 22:50
$Vincerx Pharma(VINC)$ 不畏高，追涨。
Vincerx Pharma(VINC)03-30 03:15
$Vincerx Pharma(VINC)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001193125-24-081994 Act: 34 Size: 10 MB 网页链接
Vincerx Pharma(VINC)03-30 04:15
$Vincerx Pharma(VINC)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001193125-24-082071 Act: 34 Size: 463 KB 网页链接
Vincerx Pharma(VINC)03-09 09:15
$Vincerx Pharma(VINC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028865 Size: 5 KB 网页链接
Vincerx Pharma(VINC)04-11 04:05
$Vincerx Pharma(VINC)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-091869 Act: 34 Size: 630 KB 网页链接
Vincerx Pharma(VINC)02-15 06:15
$Vincerx Pharma(VINC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001019056-24-000090 Act: 34 Size: 146 KB 网页链接
Vincerx Pharma(VINC)04-11 04:15
$Vincerx Pharma(VINC)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-091886 Act: 34 Size: 1 MB 网页链接
Vincerx Pharma(VINC)04-26 04:15
$Vincerx Pharma(VINC)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001193125-24-113904 Act: 34 Size: 168 KB 网页链接
Vincerx Pharma(VINC)04-27 05:15
$Vincerx Pharma(VINC)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-24-118340 Act: 34 Size: 628 KB 网页链接
Vincerx Pharma(VINC)03-09 09:05
$Vincerx Pharma(VINC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028856 Size: 5 KB 网页链接
hero1802-21 22:50
$Vincerx Pharma(VINC)$ 不畏高，追涨。查看全文
不入流资讯2023-08-22 21:21
$Vincerx Pharma(VINC)$ Vincerx Pharma Shares Jump 10% Premarket After FDA Clearance for Clinical Trial查看全文
IPO收割机2020-12-24 23:50
沙发 $VINC(VINC)$ 这个大家有想法吗 #spac#查看全文
$Vincerx Pharma(VINC)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-130054 Act: 34 Size: 119 KB 网页链接
$Vincerx Pharma(VINC)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-24-122837 Act: 33 Size: 618 KB 网页链接
$Vincerx Pharma(VINC)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-24-118340 Act: 34 Size: 628 KB 网页链接
$Vincerx Pharma(VINC)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-24-113896 Act: 33 Size: 619 KB 网页链接
$Vincerx Pharma(VINC)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001193125-24-113904 Act: 34 Size: 168 KB 网页链接
$Vincerx Pharma(VINC)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-091886 Act: 34 Size: 1 MB 网页链接
$Vincerx Pharma(VINC)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-091854 Act: 34 Size: 949 KB 网页链接
$Vincerx Pharma(VINC)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-091869 Act: 34 Size: 630 KB 网页链接
$Vincerx Pharma(VINC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000769993-24-000222 Act: 34 Size: 23 KB 网页链接
$Vincerx Pharma(VINC)$ 8-K Current report, item 8.01 Accession Number: 0001193125-24-089665 Act: 34 Size: 160 KB 网页链接